Ballentine Partners LLC raised its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 4.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 655 shares of the company’s stock after purchasing an additional 26 shares during the period. Ballentine Partners LLC’s holdings in Chemed were worth $394,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of CHE. Assenagon Asset Management S.A. acquired a new position in shares of Chemed during the third quarter worth approximately $2,301,000. Ausbil Investment Management Ltd acquired a new stake in Chemed in the 3rd quarter valued at approximately $579,000. Hennion & Walsh Asset Management Inc. bought a new stake in Chemed during the 3rd quarter valued at $293,000. International Assets Investment Management LLC acquired a new position in Chemed during the 3rd quarter worth $437,150,000. Finally, Signaturefd LLC grew its stake in shares of Chemed by 14.6% in the third quarter. Signaturefd LLC now owns 454 shares of the company’s stock worth $273,000 after purchasing an additional 58 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.
Insider Transactions at Chemed
In related news, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total transaction of $474,924.81. Following the transaction, the director now owns 5,725 shares in the company, valued at $3,271,894.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the completion of the sale, the chief executive officer now owns 105,735 shares in the company, valued at $60,229,828.05. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the transaction, the director now directly owns 5,725 shares in the company, valued at approximately $3,271,894.75. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 9,144 shares of company stock valued at $5,264,839. Company insiders own 3.32% of the company’s stock.
Chemed Stock Up 1.0 %
Chemed Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. This is an increase from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. Chemed’s payout ratio is 10.76%.
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles
- Five stocks we like better than Chemed
- What is a Special Dividend?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- How to Calculate Return on Investment (ROI)
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Why is the Ex-Dividend Date Significant to Investors?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.